Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions.

Mallery SR, Zwick JC, Pei P, Tong M, Larsen PE, Shumway BS, Lu B, Fields HW, Mumper RJ, Stoner GD.

Cancer Res. 2008 Jun 15;68(12):4945-57. doi: 10.1158/0008-5472.CAN-08-0568.

2.

Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.

Shumway BS, Kresty LA, Larsen PE, Zwick JC, Lu B, Fields HW, Mumper RJ, Stoner GD, Mallery SR.

Clin Cancer Res. 2008 Apr 15;14(8):2421-30. doi: 10.1158/1078-0432.CCR-07-4096.

3.

Topical application of a mucoadhesive freeze-dried black raspberry gel induces clinical and histologic regression and reduces loss of heterozygosity events in premalignant oral intraepithelial lesions: results from a multicentered, placebo-controlled clinical trial.

Mallery SR, Tong M, Shumway BS, Curran AE, Larsen PE, Ness GM, Kennedy KS, Blakey GH, Kushner GM, Vickers AM, Han B, Pei P, Stoner GD.

Clin Cancer Res. 2014 Apr 1;20(7):1910-24. doi: 10.1158/1078-0432.CCR-13-3159. Epub 2014 Jan 31.

4.
5.

Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries.

Han C, Ding H, Casto B, Stoner GD, D'Ambrosio SM.

Nutr Cancer. 2005;51(2):207-17.

PMID:
15860443
6.

Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study.

Varghese SS, Sunil PM, Madhavan RN.

Cancer Biomark. 2010-2011;8(3):155-60. doi: 10.3233/CBM-2011-0207.

PMID:
22012771
7.

Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.

Svec J, Musílková J, Bryndová J, Jirásek T, Mandys V, Kment M, Pácha J.

Inflamm Bowel Dis. 2010 Jul;16(7):1127-37. doi: 10.1002/ibd.21178.

PMID:
20027603
8.

Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells.

Zikri NN, Riedl KM, Wang LS, Lechner J, Schwartz SJ, Stoner GD.

Nutr Cancer. 2009;61(6):816-26. doi: 10.1080/01635580903285148.

9.
10.

Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche.

Knobloch TJ, Uhrig LK, Pearl DK, Casto BC, Warner BM, Clinton SK, Sardo-Molmenti CL, Ferguson JM, Daly BT, Riedl K, Schwartz SJ, Vodovotz Y, Buchta AJ Sr, Schuller DE, Ozer E, Agrawal A, Weghorst CM.

Cancer Prev Res (Phila). 2016 Feb;9(2):159-71. doi: 10.1158/1940-6207.CAPR-15-0187. Epub 2015 Dec 23.

11.

Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.

Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, Mochiki E, Yakabi K, Kawano T, Tamaru J, Ishida H.

Int Surg. 2015 Apr;100(4):733-43. doi: 10.9738/INTSURG-D-14-00234.1.

13.

Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma.

Nagatsuka H, Siar CH, Tsujigiwa H, Naomoto Y, Han PP, Gunduz M, Sugahara T, Sasaki A, Nakajima M.

Ann Diagn Pathol. 2012 Oct;16(5):354-61. doi: 10.1016/j.anndiagpath.2012.02.004. Epub 2012 May 8.

PMID:
22575501
14.

Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.

Sappayatosok K, Maneerat Y, Swasdison S, Viriyavejakul P, Dhanuthai K, Zwang J, Chaisri U.

Med Oral Patol Oral Cir Bucal. 2009 Jul 1;14(7):E319-24.

15.

Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.

Segawa E, Sakurai K, Kishimoto H, Takaoka K, Noguchi K, Hashitani S, Hirota S, Urade M.

Oral Oncol. 2008 Jul;44(7):664-71. Epub 2007 Nov 9.

PMID:
17996482
16.

[Expression of cyclooxygenase-2 and inducible nitric oxide synthase in tongue hyperplasia and tongue squamous cell carcinoma].

Xu GX, Chen WL, Li HG, Li JS, Yang CH, Pan CB.

Ai Zheng. 2005 Nov;24(11):1345-9. Chinese.

PMID:
16552960
17.
18.

p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.

Shahnavaz SA, Regezi JA, Bradley G, Dubé ID, Jordan RC.

J Pathol. 2000 Mar;190(4):417-22.

PMID:
10699989
20.

Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.

Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.

Head Neck. 2009 Aug;31(8):1039-48. doi: 10.1002/hed.21071.

PMID:
19340865

Supplemental Content

Support Center